{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Mirum Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"MIRM"},"Address":{"label":"Address","value":"950 TOWER LANE,SUITE 1050, FOSTER CITY, California, 94404, United States"},"Phone":{"label":"Phone","value":"+1 650 667-4085"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.mirumpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Christopher Peetz","title":"Chief Executive Officer & Director"},{"name":"Jean-Luc Samuel Francois Girardet","title":"Senior Vice President-Technical Operations"},{"name":"Joanne M. Quan","title":"Chief Medical Officer"},{"name":"Pamela Vig","title":"Chief Scientific Officer & Head-Research"},{"name":"Peter Radovich","title":"President & Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}